Influenza vaccine (split virion, inactivated, Sanofi Pasteur)

N/A

Report date: 2026/02/09 20:01:27

Base Information

Drug NameInfluenza vaccine (split virion, inactivated, Sanofi Pasteur)

Drug Alias Name流感病毒灭活裂解疫苗（赛诺菲巴斯德）IDfluIIV-HD

ClassificationVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsInfluenza, Human

Approved Indications in ChinaN/A

Original Approved Country/TerritoryEU

Original Approved Date2009/02/24

Country/TerritoryUnited StatesTaiwanEU

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesSanofi Pasteur

China Registration ClassN/A

Develop Information

Active CompaniesSanofi Pasteur

Inactive CompaniesSanofi Pasteur Sa

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02